Literature DB >> 18417072

Novel markers of inflammation in atherosclerosis.

Salim S Virani1, Venkateshwar R Polsani, Vijay Nambi.   

Abstract

Inflammation plays a key role in the pathogenesis of atherosclerosis. Understanding the process of inflammation as it pertains to atherosclerosis has provided researchers with multiple opportunities to identify novel markers for use in cardiovascular disease management. This article discusses the inflammatory cascade as it pertains to atherosclerosis and some of the well-studied markers of inflammation. It also discusses the limitations of current risk stratification models and characteristics of a good biomarker.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18417072     DOI： 10.1007/s11883-008-0024-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  56 in total

Review 1.  Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-11-11       Impact factor: 29.690

Review 2.  In search of fewer independent risk factors.

Authors:  Daniel J Brotman; Esteban Walker; Michael S Lauer; Ralph G O'Brien
Journal:  Arch Intern Med       Date:  2005-01-24

Review 3.  How to identify patients with vulnerable plaques.

Authors:  Salim S Virani; Christie M Ballantyne
Journal:  Diabetes Obes Metab       Date:  2007-10-29       Impact factor: 6.577

4.  The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.

Authors:  P Jousilahti; V Salomaa; V Rasi; E Vahtera; T Palosuo
Journal:  Atherosclerosis       Date:  2001-06       Impact factor: 5.162

Review 5.  Markers of inflammation and their clinical significance.

Authors:  Christie M Ballantyne; Vijay Nambi
Journal:  Atheroscler Suppl       Date:  2005-05       Impact factor: 3.235

Review 6.  Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

Authors:  P M Ridker
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

7.  Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Authors:  S Vehkavaara; A Silveira; T Hakala-Ala-Pietilä; A Virkamäki; O Hovatta; A Hamsten; M R Taskinen; H Yki-Järvinen
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

8.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

9.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

10.  Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.

Authors:  Marijn C Meuwese; Erik S G Stroes; Stanley L Hazen; Joram N van Miert; Jan Albert Kuivenhoven; Robert G Schaub; Nicholas J Wareham; Robert Luben; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  J Am Coll Cardiol       Date:  2007-06-21       Impact factor: 24.094
View more
  10 in total

1.  Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography.

Authors:  C Özbek; I Baran; A Tütüncü; T Kuştarcı; K Karaağaç; A Özbek
Journal:  Ir J Med Sci       Date:  2013-08-29       Impact factor: 1.568

2.  The effect of aerobic versus strength-based training on high-sensitivity C-reactive protein in older adults.

Authors:  Raul A Martins; Ana P Neves; Manuel J Coelho-Silva; Manuel T Veríssimo; Ana Maria Teixeira
Journal:  Eur J Appl Physiol       Date:  2010-05-01       Impact factor: 3.078

Review 3.  Biomarkers of atherosclerosis: clinical applications.

Authors:  Todd M Brown; Vera Bittner
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

4.  Analyses of C-Reactive Protein, Endothelial Nitric Oxide Synthase and Interleukin-6 Gene Polymorphisms in Adolescents with a Family History of Premature Coronary Artery Disease: A Pilot Study.

Authors:  Ataç Çelik; Mustafa Özçetin; Ömer Ateş; Fatih Altunkaş; Kayıhan Karaman; İlker Akar; İlker İnce; Murat Yalçın; Metin Karayakalı; Köksal Ceyhan; Fatih Koç
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

Review 5.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

6.  A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants.

Authors:  Allen Adolphe; Linda S Cook; Xun Huang
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

Review 7.  Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2010-12-09       Impact factor: 4.162

8.  Biophytum sensitivum: Ancient medicine, modern targets.

Authors:  K M Sakthivel; C Guruvayoorappan
Journal:  J Adv Pharm Technol Res       Date:  2012-04

9.  Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin.

Authors:  Ting Sha; Chunmei Qi; Wei Fu; J I Hao; Lei Gong; Hao Wu; Qingdui Zhang
Journal:  Exp Ther Med       Date:  2016-04-19       Impact factor: 2.447

Review 10.  Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well.

Authors:  Xiaoming Jia; Mahmoud Al Rifai; Aliza Hussain; Seth Martin; Anandita Agarwala; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2020-10-03       Impact factor: 5.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.